RBC Capital Downgrades Morphic Therapeutic (MORF) to Sector Perform Jul 9, 2024 03:18AM
MORF Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Morphic Holding to Eli Lilly Jul 8, 2024 09:10AM
MORF Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Morphic Holding to Eli Lilly Jul 8, 2024 09:10AM
Morphic to Participate in RBC Capital Markets Global Healthcare Conference May 9, 2024 04:05PM
Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference May 12, 2023 08:30AM


May 5, 2023 10:30AM Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 2, 2023 04:03PM Morphic Therapeutic (MORF) Announces Proposed Public Offering
May 2, 2023 04:02PM Morphic Therapeutic Announces Proposed Public Offering
May 17, 2022 08:00AM Morphic Announces Participation in 2022 RBC Capital Markets Global Healthcare Conference
Mar 3, 2021 06:07AM Morphic Therapeutic (MORF) Prices 3.5M Share Upsized Common Offering at $70/Sh
Mar 2, 2021 08:25PM Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
Mar 2, 2021 08:25PM Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
Mar 1, 2021 04:03PM Morphic Therapeutic (MORF) Announces $200M Proposed Public Offering of Common Stock
Mar 1, 2021 04:01PM Morphic Therapeutic Announces Proposed Public Offering
Mar 1, 2021 04:01PM Morphic Therapeutic Announces Proposed Public Offering
Oct 26, 2020 05:28AM RBC Capital Starts Morphic Therapeutic (MORF) at Outperform